Loading provider…
Loading provider…
Urology Physician in Honolulu, HI
NPI: 1104973908Primary Practice Location
THE QUEENS MEDICAL CENTER
1301 Punchbowl St, Honolulu, HI
Primary Employer
Island Urology Oahu LLC
islandurologyhawaii.com
HQ Phone
Get MD Sergei's Phone Numberphone_androidMobile
Get MD Sergei's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 421 | 627 |
| 2 | 81002Urinalysis, manual test | 174 | 238 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 75 | 75 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 53 | 60 |
| 5 | 51798Ultrasound measurement of bladder capacity after voiding | 37 | 44 |
Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer.
Authors: Sandeep Reddy, Patrick Soon-Shiong, Charles Rosser, Jeffrey Nix
Publication Date: 2021-05
Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer.
Authors: Yosuke Hirasawa, Ian Pagano, Runpu Chen, Yijun Sun, Yunfeng Dai, Amit Gupta, Sergei Tikhonenkov, Steve Goodison, Charles Rosser, Hideki Furuya
Publication Date: 2021-02-19
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Lead Sponsor: University of Hawaii
Collaborators: University of Hawaii Cancer Research Center
Intervention / Treatment: DRUG: Noni extract
Lead Sponsor: ImmunityBio, Inc.
Intervention / Treatment: DRUG: N-803, DRUG: N-803 and BCG